Germ cell tumors (GCTs) are rare cancers in children, making up only 3% of childhood cancers. They may develop in the ovaries, testes, or even in the brain. Regular therapies, such as surgery and ...

The Python team at Microsoft is continuing its overhaul of environment management in Visual Studio Code, with the August 2025 release advancing the controlled rollout of the new Python Environments ...

ALBANY, N.Y. — School is starting back up in just a matter of weeks, and New York State is helping keep parents informed on the new statewide cellphone ban in the classroom. On Thursday, the state ...

Rochester, N.Y. — New York state has launched a new website allowing anyone to look up details of each public and charter school's plan to comply with the state's impending restrictions on cellphones ...

From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to make CGTs commercially viable. But it is possible, experts agreed at a recent ...

'Vibe coding' — the act of letting AI code for you instead of creating the code manually — has become a popular method for speeding up coding projects and cutting down on human involvement in the ...

A tech entrepreneur named Jason Lemkin set out to document his experience using an AI “vibe coding” tool called Replit to make an app. But the “vibes” turned bad real quick. The AI wiped out a key ...

Background: Existing research on the development of prognostic models for renal cell carcinoma (RCC) patients with brain metastases (BM) remains limited. This study aimed to develop a prognostic ...

A new Florida law restricts cellphone use for elementary and middle school students during school hours, with looser regulations for high schoolers. Brevard County's school board is moving towards a ...

The framework of CASHeart. (A) Overview of the data collection and data processing workflow in the CASHeart Database. (B) Introduction to the main interfaces of the CASHeart website. The human heart ...

Racial and socioeconomic disparities in molecular testing and targeted therapy utilization among patients with advanced non-small cell lung cancer: A National Cancer Database analysis. This is an ASCO ...